Microbot Medical Inc. (MBOT)

0.8780 -0.0130 (-1.46%) As of 01:17PM EDT. Market open.

Microbot Medical Inc.

288 Grove Street
Suite 388
Braintree, MA 02184
United States
781 875 3605
https://www.microbotmedical.com

Sector(s): Healthcare
Industry: Medical Instruments & Supplies
Full-time employees: 21

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Harel Gadot	Co-Founder, President, CEO & Chairman	813.82k	N/A	1973
Mr. Yoseph Bornstein	Co-Founder & Independent Director	13.12k	N/A	1959
Ms. Rachel Vaknin	Chief Financial Officer	212.97k	N/A	1980
Dr. Simon Sharon MBA, MSc	CTO & GM of Microbot Israel	381.51k	N/A	1961
Dr. Juan Diaz-Cartelle	Chief Medical Officer	N/A	N/A	1976

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Microbot Medical Inc. operates as a pre-clinical medical device company in the United Kingdom. It primarily engages in the research, design, and development of next generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company also offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. In addition, it provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company also has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.

Corporate governance

Microbot Medical Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.